Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.60) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.60) per share from the same period last year.
Chevron, Chubb, Toast And More On CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Shannon Saccocia of NB Private Wealth named iShares S&P GSCI Commodity-Indexed Trust (NYSE: GSG)
